Retinopathy of Prematurity
At a Glance
Retinopathy of Prematurity is an eye disorder affecting premature infants in which abnormal blood vessels grow in the retina, the layer of nerve tissue at the back of the eye that enables us to see, potentially leading to scarring and retinal detachment.
This condition occurs exclusively in premature infants, typically those born before 31 weeks of gestation or weighing less than 2.75 pounds (1,250 grams), and affects a significant percentage of these high-risk babies.
It is an acute condition that develops shortly after birth but can lead to chronic, lifelong vision problems if severe scarring or retinal detachment occurs.
The outlook is generally positive as most mild cases resolve without treatment, but severe cases require timely intervention to prevent permanent blindness and ensure the best possible visual quality of life.
How It Affects You
Retinopathy of Prematurity (ROP) primarily affects the eyes, specifically the retina, which is the light-sensitive tissue lining the back of the eye. In this condition, blood vessels in the retina develop abnormally, potentially leading to scarring and tension that can pull the retina away from the wall of the eye. This disruption can result in the following:
- Permanent vision impairment or blindness due to retinal detachment.
- Development of long-term eye conditions such as nearsightedness (myopia), crossed eyes (strabismus), or lazy eye (amblyopia).
- Structural changes to the eye that may require surgical intervention or lifelong monitoring.
Causes and Risk Factors
Causes and Mechanisms
Retinopathy of Prematurity (ROP) is caused by the interruption of normal blood vessel development in the eye. The blood vessels that feed the retina usually finish developing only a few weeks before a full-term birth. When an infant is born prematurely, this growth stops. Later, as the eye attempts to catch up, the vessels may grow abnormally (neovascularization) and randomly. These new vessels are fragile and can leak blood, leading to scar tissue formation. As this scar tissue shrinks, it can pull on the retina, causing it to detach from the back of the eye.
Risk Factors
The most significant risk factors involve the degree of prematurity and the overall health of the infant. Key factors include:
- Premature Birth: Infants born before 31 weeks of gestation are at highest risk.
- Low Birth Weight: Babies weighing usually less than 2¾ pounds (about 1,250 grams) are significantly more susceptible.
- Oxygen Therapy: While oxygen is necessary for survival, high levels or fluctuating levels of supplemental oxygen can trigger abnormal vessel growth.
- General Health: Complications such as anemia, poor weight gain, blood transfusions, respiratory distress, or breathing pauses (apnea) can increase risk.
Prevention
Primary prevention focuses on preventing premature births through comprehensive prenatal care. For infants already born prematurely, neonatal intensive care units (NICUs) use strict protocols to monitor and regulate oxygen levels to minimize the risk of ROP while ensuring the baby breathes adequately. Screening programs are the most effective tool for preventing the progression of the disease; identifying ROP early allows for treatment that can prevent vision loss.
Diagnosis, Signs, and Symptoms
Signs and Symptoms
In the early and treatable stages of Retinopathy of Prematurity, there are no visible signs that a parent can see. The baby’s eyes will look normal to the naked eye. Visible symptoms typically appear only in severe, advanced cases where retinal detachment has already occurred or is imminent. These late signs may include:
- Leukocoria: The pupil appears white instead of black (white pupillary reflex).
- Nystagmus: Abnormal, rhythmic shaking or wandering movements of the eyes.
- Strabismus: The eyes may appear crossed or misaligned.
Diagnosis and Screening
Because early symptoms are invisible, diagnosis relies entirely on routine screening exams performed by a pediatric ophthalmologist. Doctors use specific criteria, such as birth weight and gestational age, to determine which babies need screening. The exam involves:
- Dilation: Eye drops are used to widen the pupil.
- Indirect Ophthalmoscopy: The doctor uses a specialized headset and lens to look through the pupil and examine the blood vessels at the very back of the eye.
Differential Diagnosis
Clinicians must differentiate ROP from other conditions that cause similar retinal issues or white pupils in infants, such as familial exudative vitreoretinopathy (FEVR), Norrie disease, or retinoblastoma (a rare eye cancer), though the context of prematurity usually makes ROP the primary suspect.
Treatment and Management
Medical and Surgical Treatments
Treatment is reserved for cases where the abnormal vessels threaten to detach the retina. Options include:
- Laser Therapy (Photocoagulation): This is the standard treatment. A laser is used to burn the peripheral area of the retina that lacks normal blood vessels. This stops the release of chemical signals causing the abnormal growth, preserving the central vision.
- Anti-VEGF Injections: Medications are injected into the eye to block the protein (VEGF) that stimulates abnormal vessel growth. This allows vessels to grow more normally but requires close long-term monitoring for recurrence.
- Scleral Buckle: A silicone band is placed around the eye to push the wall inward, relieving traction on the retina in cases of detachment.
- Vitrectomy: A surgery to remove the vitreous gel and scar tissue pulling on the retina, used in the most severe detachment cases.
Monitoring and Follow-Up
Most babies with ROP do not need treatment, only close observation. Exams may occur every 1 to 2 weeks until the blood vessels have matured. Long-term follow-up is essential even after the condition resolves, as these children are at higher risk for vision issues later in childhood.
When to See a Doctor
Since ROP screening happens automatically in the NICU for at-risk infants, parents should focus on attending all scheduled outpatient follow-up appointments after discharge. Seek medical advice if you notice:
- The baby does not track objects or faces.
- The eyes seem crossed or wander independently after 4 months of age.
- One or both pupils look white or cloudy in photos or specific lighting.
Severity and Prognosis
Severity Classifications
Doctors classify ROP by "Zones" (location in the eye) and "Stages" (severity of vessel growth).
- Stage 1 & 2: Mildly abnormal vessel growth. Most of these cases improve on their own without treatment.
- Stage 3: Severe abnormal vessel growth. Treatment is often considered at this stage to prevent detachment.
- Stage 4: Partial retinal detachment.
- Stage 5: Total retinal detachment, which often leads to blindness.
- Plus Disease: A condition where vessels become twisted and enlarged, indicating a rapidly progressive and severe form of ROP.
Prognosis and Duration
The disease typically follows a timeline based on the infant's corrected gestational age, often peaking around 36 to 40 weeks and resolving by a few months of age. The prognosis for early stages is excellent. If treated promptly with laser or injections, the risk of blindness is low. However, if the retina detaches (Stage 4 or 5), the visual prognosis remains guarded even with surgery.
Long-Term Effects
Even if ROP resolves or is treated successfully, children have a higher lifelong risk of other eye problems, including:
- Severe nearsightedness (myopia).
- Amblyopia (lazy eye).
- Strabismus (misalignment).
- Glaucoma or cataracts later in life.
- Late-onset retinal detachment.
Impact on Daily Life
Impact on Activities and Development
For most children whose ROP resolves, daily life is normal, though they may need glasses earlier than their peers. For those with vision loss, early intervention services are crucial to help them develop motor and language skills. Parents play a key role in providing visual stimulation and maintaining a safe environment. Children with partial vision may require large-print materials or sitting closer to the front in school.
Coping and Support
The diagnosis can be terrifying for parents already dealing with the stress of a NICU stay. Support groups for parents of preemies can be invaluable. It is important to treat the child normally while remaining vigilant about eye health. Routine eye exams will be a regular part of life to monitor for refractive errors like nearsightedness.
Questions to Ask Your Healthcare Provider
- What stage and zone is my baby’s ROP currently in?
- Does my baby have "Plus disease"?
- How often do we need to return for follow-up eye exams after leaving the hospital?
- What specific signs of vision trouble should I watch for at home?
- Are there any lifestyle changes or environmental factors I should be aware of to protect my child's vision?
- If treatment is needed, what are the specific risks and benefits of laser therapy versus injections for my child's specific case?
Common Questions and Answers
Q: Will my baby go blind from ROP?
A: Most babies with ROP do not go blind. The vast majority of cases are mild and correct themselves. However, if the disease progresses to severe stages and is left untreated, it can cause blindness, which is why screening exams are so important.
Q: Did oxygen therapy cause my baby's ROP?
A: Oxygen is a contributing factor, but it is not the sole cause. Premature babies often need oxygen to survive and protect their brain and organs. Doctors carefully monitor oxygen levels to balance these needs with the risk of eye damage.
Q: Is the eye exam painful for the baby?
A: The exam can be uncomfortable and stressful for the baby because of the bright light and the instrument used to keep the eye open. Doctors often use numbing drops and comfort measures (like swaddling or sucrose) to minimize distress.
Q: Can ROP come back after treatment?
A: Yes, recurrence is possible, especially with anti-VEGF injection treatments. This is why long-term follow-up appointments are critical to ensure the blood vessels continue to develop normally.
Q: Is ROP hereditary?
A: ROP is generally not considered a hereditary condition. It is primarily caused by premature birth and the interruption of normal development, although genetic factors may play a minor role in how susceptible a specific baby is to the condition.